Drs. McDonell and Ries are currently conducting research on the efficacy of psychosocial drug and alcohol treatments (e.g., contingency management) delivered in a community mental health setting for adults who suffer from co-occurring serious mental illness. Dr. Ries' RO1 investigating the efficacy of CM for psycho-stimulant use (cocaine) has a vast amount of data available for secondary data analysis. Drs. McDonell and Ries recently began (PI: McDonell) an NIAAA funded RO1 study investigating the efficacy of CM as a treatment for alcohol use disorders (using a novel alcohol biomarker, ethyl glucuronide) in an SMI population. Their research group is also focused on studies investigating the validity and reliability of self-report, clinician ratings, and biomarkers of substance use and psychiatric severity in COD populations.
Fellows will have the opportunity to participate actively in this dynamic lab with ample opportunities and support to pursue their own research interests in the treatment of CODs. Clinically, fellows will have the opportunity to provide assessment and treatment of adults with CODs at Harborview's Community Mental Health Center, as well as other treatment opportunities available through other addiction focused services at HMC (e.g., motivational interviewing as part of the Consultation Liaison service in the general hospital).